This blog is related to the various litigations related to patents w.r.t pharma industry.
Monday, August 17, 2009
US FDA Approves Extavia
August 17, 2009 - The US FDA has approved Extavia® (interferon beta-1b), the first in a new planned portfolio of multiple sclerosis (MS) medicines from Novartis to help patients manage this devastating disease.
No comments:
Post a Comment